Latest filing published 20 Dec 2012 for DUSA PHARMACEUTICALS INC, €36k.
No signal scores available.
This profile gathers the share dealings of Paul J. Hondros in Dusa Pharmaceuticals Inc. The record holds 4 filings, for trades running from 30 June 2011 to 20 December 2012.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 20 December 2012 with a transaction (€36k) in Dusa Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations